Criteria
Leader criteria
Sector
Communication Services
79
Consumer Discretionary
295
Consumer Staples
105
Energy
124
Financials
468
Health Care
449
Industrials
476
Information Technology
428
Materials
222
Real Estate
118
Utilities
77
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Russell 3000
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRGO | Perrigo Co Plc | Health Care | $15.78 | down 1.1% | up 6.9% | down 18.1% | 4.0% | 83 | 8/8 | $2.2B | — | — | down 39% | 0.7× | 1.23 | — | 4/9 | Elevated | |
| PRME | Prime Medicine, Inc. | Health Care | $4.72 | up 28.6% | up 54.5% | up 8.5% | 9.6% | 91 | 7/8 | $852.0M | — | — | down 147% | 7.0× | — | — | — | Elevated | |
| PROK | Prokidney Corp. | Health Care | $1.29 | down 8.2% | down 22.0% | down 58.0% | 9.0% | 7 | 0/8 | — | — | — | — | — | — | — | — | Unknown | |
| PRTA | Prothena Corp Public Ltd Co | Health Care | $8.47 | up 3.3% | up 1.1% | down 19.2% | 5.1% | 30 | 1/8 | $456.0M | — | — | down 64% | 1.6× | — | — | — | Elevated | |
| PRVA | Privia Health Group, Inc. | Health Care | $21.48 | down 4.1% | up 9.1% | down 12.4% | 2.9% | 25 | 3/8 | $2.7B | 115.8× | 2.10 | up 3% | 3.6× | — | up 228% | — | Low | |
| PSNL | Personalis, Inc. | Health Care | $15.82 | down 0.2% | down 2.8% | up 66.4% | 2.2% | 96 | 7/8 | $1.6B | — | — | down 35% | 6.2× | — | — | 4/9 | Elevated | |
| PTCT | Ptc Therapeutics, Inc. | Health Care | $59.97 | down 1.0% | down 7.4% | down 12.0% | 4.0% | 23 | 1/8 | $4.9B | 7.2× | — | — | — | — | down 439% | — | Elevated | |
| PTGX | Protagonist Therapeutics, Inc | Health Care | $144.85 | up 4.6% | up 2.8% | up 86.1% | 3.6% | 92 | 8/8 | $9.1B | — | — | down 20% | 14.7× | — | — | — | Low | |
| PVLA | Palvella Therapeutics, Inc. | Health Care | $146.15 | up 16.8% | up 6.0% | up 86.4% | 5.1% | 91 | 8/8 | $1.8B | — | — | down 92% | 64.7× | — | — | — | Unknown | |
| QDEL | Quidelortho Corp | Health Care | $13.25 | down 3.5% | up 25.7% | down 50.6% | 7.7% | 9 | 2/8 | $899.7M | — | — | down 46% | 0.5× | 1.40 | — | — | Elevated | |
| QGEN | Qiagen N.V. | Health Care | $50.22 | down 0.3% | up 14.8% | up 9.4% | 2.1% | 74 | 7/8 | $10.9B | 25.6× | 0.06 | up 12% | 2.9× | 0.44 | — | 8/9 | Low | |
| QURE | Uniqure N.V. | Health Care | $24.83 | up 10.7% | up 2.8% | down 63.4% | 7.1% | 13 | 3/8 | $1.5B | — | — | down 100% | 7.8× | 0.25 | — | 2/9 | Elevated | |
| RAPP | Rapport Therapeutics, Inc. | Health Care | $25.05 | down 3.4% | down 25.4% | down 6.8% | 10.7% | 12 | 1/8 | $1.2B | — | — | down 28% | 2.5× | — | — | — | Unknown | |
| RARE | Ultragenyx Pharmaceutical Inc. | Health Care | $16.10 | up 2.9% | up 7.1% | down 54.2% | 5.3% | 5 | 1/8 | $1.6B | — | — | — | — | — | — | — | Elevated | |
| RCEL | Avita Medical, Inc. | Health Care | $15.65 | up 0.9% | up 33.4% | — | 5.5% | — | — | $478.4M | — | — | — | — | — | — | 3/9 | Elevated | |
| RCUS | Arcus Biosciences, Inc. | Health Care | $18.19 | down 1.9% | down 29.6% | down 9.9% | 7.9% | 12 | 1/8 | $2.3B | — | — | down 63% | 3.6× | 0.16 | — | — | Elevated | |
| RDNT | Radnet, Inc. | Health Care | $73.49 | up 4.5% | up 6.6% | down 3.4% | 3.2% | 62 | 5/8 | $5.7B | — | — | down 2% | 5.2× | 0.98 | down 50% | — | Moderate | |
| RDY | Dr Reddys Laboratories Ltd | Health Care | $14.17 | up 7.3% | up 12.3% | up 6.1% | 2.1% | 63 | 3/8 | — | — | — | — | — | — | — | — | Unknown | |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | $927.89 | up 15.3% | up 22.4% | up 42.6% | 2.9% | 85 | 7/8 | — | — | — | up 15% | — | 0.06 | up 35% | — | Unknown | |
| REPL | Replimune Group, Inc. | Health Care | $17.61 | up 53.7% | up 33.0% | up 71.8% | 6.4% | 99 | 8/8 | $1.5B | — | — | down 108% | 8.8× | 0.50 | — | — | Unknown | |
| RGC | Regencell Bioscience Holdings Ltd | Health Care | $6.71 | down 12.5% | up 7.9% | down 59.0% | 15.2% | 5 | 1/8 | $3.3B | — | — | down 55% | 682.7× | — | — | — | Unknown | |
| RGEN | Repligen Corp | Health Care | $176.94 | 0.0% | down 8.0% | up 22.4% | 5.3% | 82 | 7/8 | $10.0B | 203.8× | — | up 2% | 4.7× | 0.26 | down 358% | 6/9 | Low | |
| RGNX | Regenxbio Inc. | Health Care | $7.20 | up 7.8% | down 4.4% | down 43.8% | 6.8% | 8 | 0/8 | $366.4M | — | — | down 107% | 3.6× | — | — | — | Elevated | |
| RIGL | Rigel Pharmaceuticals Inc | Health Care | $51.31 | up 6.6% | up 6.6% | up 62.3% | 3.2% | 94 | 8/8 | $939.5M | 2.6× | 0.00 | up 186% | 2.4× | 0.13 | down 73% | 7/9 | Low | |
| RLAY | Relay Therapeutics, Inc. | Health Care | $18.35 | up 0.9% | up 1.7% | up 150.0% | 5.4% | 95 | 7/8 | $3.2B | — | — | down 41% | 5.6× | — | — | — | Low |